Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy

In the past decade, the development of two innovative technologies, namely, induced pluripotent stem cells (iPSCs) and the CRISPR Cas9 system, has enabled researchers to model diseases derived from patient cells and precisely edit DNA sequences of interest, respectively. In particular, Duchenne musc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gee, Peter, Xu, Huaigeng, Hotta, Akitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451761/
https://www.ncbi.nlm.nih.gov/pubmed/28607562
http://dx.doi.org/10.1155/2017/8765154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451761/
https://www.ncbi.nlm.nih.gov/pubmed/28607562
http://dx.doi.org/10.1155/2017/8765154

Ejemplares similares